Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down ...

Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited ...

Events like the RFK Jr nomination as US HHS head, Labour’s 10-year plan, and centralised EU funding will steer the sector’s ...

RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.

Technology has changed the clinical trial landscape forever, with application programming interfaces (APIs) growing in ...

TV personality Dr Oz has been nominated by President-elect Donald Trump to lead the Centers for Medicare and Medicaid ...

Samsung Biologics has announced another significant manufacturing agreement, securing a $668m contract with a Europe-based ...

The companies have teamed up to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell ...

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.

HYMPAVZI is a once-weekly subcutaneous treatment option for individuals with severe haemophilia A or B. Credit: ...

Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to ...